Optimize Immuno-oncology Drug Discovery and Development Using QSP
A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…
CertaraJune 19, 2019
PBPK’s Pivotal Role in Modern Drug Development: Busting Common Myths and Misconceptions
This white paper addresses common PBPK myths and misconceptions and demonstrates how this approach is…
CertaraFebruary 4, 2019
Best Practices for Developing High Quality, On Time Submissions
Sponsors often struggle with submission planning. Read this white paper to learn how to develop…
CertaraJanuary 8, 2018
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal
Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…
CertaraAugust 24, 2017
Model-based Meta-analysis: An Innovative Methodology Comes of Age
MBMA integrates internal and external drug development data to inform proprietary commercial and R&D decisions.…
CertaraJuly 14, 2016
Transform Your Early Drug Development with Population Pharmacokinetic Analysis
Population pharmacokinetic analysis has become a key tool for Clinical Pharmacology experts when working with…
CertaraApril 19, 2016
